We are live on ! Find out more
SAM

Senzar Asset Management Portfolio holdings

AUM $34.7M
1-Year Est. Return 0.56%
This Fund
S&P 500
This Quarter Est. Return
-17.68%
1 Year Est. Return
+0.56%
3 Year Est. Return
-0.75%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$687M
AUM Growth
+$105M
Cap. Flow
+$243M
Cap. Flow %
35.31%
Top 10 Hldgs %
70.66%
Holding
51
New
13
Increased
20
Reduced
3
Closed
15

Top Buys

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$82.8M
2
NVRO
NEVRO CORP.
NVRO
+$58.1M
3
AET
Aetna Inc
AET
+$49.4M
4
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$42.6M
5
AMGN icon
Amgen
AMGN
+$32.7M

Top Sells

Rank Stock Value
1
LH icon
Labcorp
LH
+$51.3M
2
PRGO icon
Perrigo
PRGO
+$36.6M
3
BDX icon
Becton Dickinson
BDX
+$20.8M
4
RCPT
RECEPTOS INC COM STK (DE)
RCPT
+$17.1M
5
MDT icon
Medtronic
MDT
+$16.9M

Sector Composition

Rank Sector Weight
1 Healthcare 83.9%
2 Financials 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVRO
1
DELISTED
NEVRO CORP.
NVRO
$102M 14.88%
2,205,181
+1,198,702
+119% +$58.1M
VTRS icon
2
Viatris
VTRS
$19.8B
$69.2M 10.07%
1,719,184
+1,485,400
+635% +$82.8M
TEVA icon
3
Teva Pharmaceuticals
TEVA
$36.1B
$68.6M 9.97%
1,214,494
+336,997
+38% +$21.9M
STJ
4
DELISTED
St Jude Medical
STJ
$54.9M 7.99%
870,300
+307,600
+55% +$22M
AET
5
DELISTED
Aetna Inc
AET
$54M 7.85%
493,404
+427,404
+648% +$49.4M
CNCE
6
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$30.9M 4.49%
1,645,673
+88,139
+6% +$1.5M
AMGN icon
7
Amgen
AMGN
$197B
$28.7M 4.17%
+207,400
New +$32.7M
MNK
8
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$27.5M 4%
+430,200
New +$42.6M
BIIB icon
9
Biogen
BIIB
$29.5B
$26.1M 3.8%
+89,500
New +$29.6M
TVTY
10
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$23.6M 3.43%
2,119,037
+678,534
+47% +$8.29M
CI icon
11
Cigna
CI
$75.1B
$23.4M 3.41%
173,600
+97,300
+128% +$14.1M
ITCI
12
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$22.3M 3.24%
556,224
+394,924
+245% +$12.9M
ALDR
13
DELISTED
Alder Biopharmaceuticals
ALDR
$18M 2.62%
+549,900
New +$23.4M
TVTX icon
14
Travere Therapeutics
TVTX
$5.16B
$14.6M 2.13%
722,100
+512,600
+245% +$15.2M
SPNC
15
DELISTED
Spectranetics Corp
SPNC
$12.1M 1.75%
1,022,512
+882,112
+628% +$15.8M
CORI
16
DELISTED
Corium International, Inc.
CORI
$11.3M 1.64%
1,204,721
+391,636
+48% +$4.69M
INSM icon
17
Insmed
INSM
$23.2B
$10.7M 1.55%
575,407
+111,100
+24% +$2.77M
ANIP icon
18
ANI Pharmaceuticals
ANIP
$1.77B
$10.7M 1.55%
+270,040
New +$15.4M
ELOS
19
DELISTED
Syneron Medical Ltd
ELOS
$8.52M 1.24%
1,191,510
+49,810
+4% +$479K
TNDM icon
20
Tandem Diabetes Care
TNDM
$1.24B
$7.63M 1.11%
86,565
+610
+0.7% +$71K
XNPT
21
DELISTED
XENOPORT, INC.
XNPT
$7.46M 1.09%
2,150,090
+427,990
+25% +$2.7M
ACOR
22
DELISTED
Acorda Therapeutics
ACOR
$7.02M 1.02%
+2,206
New +$8.56M
DERM
23
DELISTED
Dermira, Inc.
DERM
$6.89M 1%
+295,300
New +$7.17M
FOMX
24
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$6.34M 0.92%
864,408
+156,959
+22% +$1.6M
OFIX icon
25
Orthofix Medical
OFIX
$467M
$4.56M 0.66%
134,984
-225,017
-63% -$8.01M
1
2 3

Similar funds

BCP
Blum Capital Partners San Francisco, California $34.1M AUM 1.14% 1-Year Est. Return
PRHC
P.R. Herzig & Co Roslyn Heights, New York $45.9M AUM 15.88% 1-Year Est. Return
NAM
Needelman Asset Management Ladera Ranch, California $46M AUM 8.27% 1-Year Est. Return
GG
Gores Group Beverly Hills, California $22.3M AUM 4.58% 1-Year Est. Return
SM
SLS Management New York $17.2M AUM 14.82% 1-Year Est. Return
BC
Breogan Capital New York $56.4M AUM
SCPM
Social Capital PEP Management Palo Alto, California $56.5M AUM
FAM
Fortaleza Asset Management Chicago, Illinois $12.3M AUM 48.33% 1-Year Est. Return

Senzar Asset Management's Q3 2015 Portfolio in Review

As of Q3 2015, Senzar Asset Management held 51 positions worth $687M, up 18% from $582M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Senzar Asset Management deployed $243M of net new capital in Q3 2015, opening 13 new positions and adding to 20 existing holdings. Its largest new stake was MALLINCKRODT PUBLIC LIMITED COMPANY: 430,200 shares worth $27.5M.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 81% a quarter earlier, followed by Financials.

On the sell side, the largest reduction was Orthofix Medical, an estimated $8.01M trimmed.

  • Senzar Asset Management's largest Q3 2015 buy was MALLINCKRODT PUBLIC LIMITED COMPANY: 430,200 shares worth $27.5M.
  • Senzar Asset Management added most to Viatris in Q3 2015, an estimated $82.8M increase.
  • Senzar Asset Management's biggest Q3 2015 reduction was Orthofix Medical, cutting an estimated $8.01M.
  • Senzar Asset Management fully exited Labcorp in Q3 2015, selling an estimated $51.3M.
  • Senzar Asset Management's ten largest holdings make up 71% of its $687M portfolio in Q3 2015.
  • Senzar Asset Management opened 13 new positions and closed 15 in Q3 2015.
  • Senzar Asset Management's portfolio value rose 18% quarter-over-quarter to $687M.

Based on Senzar Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.